Medistim ASA
OSE:MEDI
Medistim ASA
OSE:MEDI
Price:
163
NOK
1.88%
Market Cap:
3B
NOK
Balance Sheet
Balance Sheet Decomposition
Medistim ASA
Medistim ASA
| Current Assets | 429.1m |
| Cash & Short-Term Investments | 179.2m |
| Receivables | 89.4m |
| Other Current Assets | 160.5m |
| Non-Current Assets | 145.8m |
| PP&E | 73.2m |
| Other Non-Current Assets | 72.7m |
Balance Sheet
Medistim ASA
Medistim ASA
Currency: NOK
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
49
|
31
|
54
|
47
|
67
|
72
|
129
|
144
|
154
|
179
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
144
|
0
|
0
|
|
| Cash Equivalents |
49
|
31
|
54
|
47
|
67
|
72
|
129
|
0
|
154
|
179
|
|
| Total Receivables |
45
|
48
|
56
|
71
|
62
|
61
|
80
|
114
|
88
|
89
|
|
| Accounts Receivables |
45
|
48
|
56
|
71
|
62
|
57
|
69
|
102
|
74
|
69
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
4
|
11
|
13
|
13
|
20
|
|
| Inventory |
47
|
59
|
63
|
64
|
90
|
113
|
97
|
114
|
145
|
161
|
|
| Other Current Assets |
9
|
8
|
6
|
8
|
9
|
0
|
0
|
13
|
12
|
0
|
|
| Total Current Assets |
150
|
147
|
179
|
190
|
229
|
246
|
306
|
386
|
392
|
429
|
|
| PP&E Net |
14
|
18
|
26
|
32
|
65
|
65
|
59
|
51
|
57
|
73
|
|
| PP&E Gross |
14
|
18
|
26
|
32
|
65
|
65
|
59
|
51
|
57
|
0
|
|
| Accumulated Depreciation |
37
|
41
|
46
|
52
|
64
|
79
|
96
|
113
|
133
|
0
|
|
| Intangible Assets |
37
|
34
|
28
|
26
|
24
|
19
|
16
|
22
|
31
|
59
|
|
| Goodwill |
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
0
|
|
| Note Receivable |
0
|
0
|
2
|
5
|
2
|
2
|
4
|
6
|
6
|
4
|
|
| Other Long-Term Assets |
4
|
3
|
3
|
2
|
3
|
1
|
3
|
4
|
5
|
9
|
|
| Other Assets |
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
0
|
|
| Total Assets |
219
N/A
|
217
-1%
|
251
+16%
|
270
+7%
|
336
+25%
|
346
+3%
|
403
+17%
|
483
+20%
|
506
+5%
|
575
+14%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
13
|
8
|
14
|
12
|
15
|
14
|
13
|
24
|
25
|
18
|
|
| Accrued Liabilities |
11
|
12
|
11
|
16
|
19
|
12
|
22
|
26
|
17
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
4
|
5
|
3
|
9
|
10
|
7
|
7
|
8
|
9
|
|
| Other Current Liabilities |
27
|
24
|
28
|
25
|
29
|
24
|
35
|
43
|
44
|
80
|
|
| Total Current Liabilities |
56
|
48
|
58
|
55
|
71
|
59
|
78
|
100
|
94
|
107
|
|
| Long-Term Debt |
6
|
2
|
11
|
8
|
27
|
29
|
17
|
10
|
9
|
25
|
|
| Other Liabilities |
1
|
1
|
0
|
0
|
1
|
0
|
3
|
5
|
4
|
6
|
|
| Total Liabilities |
63
N/A
|
50
-20%
|
68
+35%
|
63
-8%
|
99
+58%
|
89
-10%
|
97
+9%
|
115
+18%
|
108
-6%
|
138
+28%
|
|
| Equity | |||||||||||
| Common Stock |
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Retained Earnings |
109
|
118
|
134
|
157
|
186
|
205
|
246
|
303
|
327
|
364
|
|
| Additional Paid In Capital |
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
2
|
3
|
4
|
4
|
6
|
13
|
19
|
25
|
26
|
|
| Total Equity |
156
N/A
|
167
+7%
|
183
+10%
|
207
+13%
|
237
+15%
|
257
+8%
|
306
+19%
|
368
+20%
|
398
+8%
|
437
+10%
|
|
| Total Liabilities & Equity |
219
N/A
|
217
-1%
|
251
+16%
|
270
+7%
|
336
+25%
|
346
+3%
|
403
+17%
|
483
+20%
|
506
+5%
|
575
+14%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
18
|
18
|
18
|
18
|
18
|
18
|
18
|
18
|
18
|
18
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
